The View from Pharma-dur

Dr. Joan Bushwell's Chimpanzee Refuge

Category archives for The View from Pharma-dur

Three pant-hoots and a grooming session to my very favorite cheeky pharma-insider monkey over at PharmaGossip (see the Chimp Refuge Blogroll) for the following, Can Peter Rost be silenced? including the link therein which led me to… …the reprint of the article on Peter Rost in Fortune Magazine, posted on Dr. Rost’s blog: Fortune: “Peter…

Orac clearly knows too much. For an accurate look at a Big Pharma board room, check out The pharma conspiracy acts against a threat. Orac, with his delightful and respectful insolence, reveals why Dan Olmsted, Thimerosal-Conspiracy- Crusader Extraordinaire, is actually Pharma’s Best Friend. Orac’s characterization of MegaPharmCo’s head honcho, ESB, is pretty accurate, too, e.g.,…

Sip from me and obey!

As much as it pains me (1) to honor the request (2) by Dave of The World’s Fair, I’ll play: 1. Can you show us your coffee cup? Here’s my work-a-day mug at my desk flanked by its friends (see answer to item 3). This photo, taken with the marginal little camera in my PDA,…

Long time no see. I took something of a hiatus from the hootacular environs of the Refuge due to the Most Wonderful Time of the Year at DOPI:* performance reviews for 2006 and objectives setting for 2007. I know. I shouldn’t whine and bitch about this, seeing how much work you academics put into the…

Let’s see, the Biz shot its right foot with the Vioxx debacle, then its left foot with Zyprexa (and others, but that’s a recent one), so now it must look for another site for further damage of its tattered n’ shattered image. Hmmm, how about lobbing off a couple of fingers? The FDA’s approval of…

A Healthy Dose of Skepticism

With the latest Big Pharma debacle (“Hey, let’s shoot ourselves in the other foot”) from the Prozacasaurus’ overmarketing of Zyprexa (see Grrl’s, Jake’s, and David’s (addendum, 12/21) blog entries on the subject), this recent (and free access) article from PLoS Medicine: Educating Health Professionals about Drug and Device Promotion: Advocates’ Recommendations seems particularly relevant.

Over at Terra Sigillata, Abel Pharmboy dissects the deeper meaning of the Rozarem ad which features Abe Lincoln, a beaver and a scuba diver telling an insomniac how much they miss him. The ad is hawking Takeda Pharm’s latest little sleeping pill. The Rozarem campaign is a departure from the usual direct-to-consumer drug advertising. It’s…

Paracetamoxyfrusebendroneomycin

A pant-hoot of appreciation goes out to United Kingdom bonobo, grimupnorth, for passing this along. Adam Kay is a junior doctor from the UK who passes his limited spare time by writing songs, including one about a new wonder-drug called Paracetamoxyfrusebendroneomycin. He’s built up a cult following, and he’s currently selling out at the Edinburgh…

After being buggery-augered with no lube by the New England Journal of Medicine’s finest, it’s refreshing for us minions of Big Bad Pharma and our small company lampreys to read an article in that august journal which moves beyond Angellic knee jerk histrionics. Alastair J.J. Wood, M.D. offers a proposal for radical changes in the…

When Gleevec hit the market in 2001 for chronic myelogenous leukemia , it was hailed as a major breakthrough in cancer treatment. Gleevec, which inhibits bcr-abl kinase, was the harbinger of targeted chemotherapy and represented a departure from the cytotoxics which, although effective, possess a broad array of adverse effects. A History of STI 571,…